Abstract
AbstractWe introduce an NAD(P)H‐sensitive polymer dot (Pdot) biosensor for point‐of‐care monitoring of metabolites. The Pdot is combined with a metabolite‐specific NAD(P)H‐dependent enzyme that catalyzes the oxidation of the metabolite, generating NAD(P)H. Upon UV illumination, the NAD(P)H quenches the fluorescence emission of Pdot at 627 nm via electron transfer, and also fluoresces at 458 nm, resulting in a shift from red to blue emission at higher NAD(P)H concentrations. Metabolite concentration is quantified ratiometrically‐based on the ratio of blue‐to‐red channel emission intensities, with a digital camera‐with high sensitivity and specificity. We demonstrate phenylalanine biosensing in human plasma for a phenylketonuria screening test, quantifying several other disease‐related metabolites (lactate, glucose, glutamate, and β‐hydroxybutyrate), and a paper‐based assay with smartphore imaging for point‐of‐care use.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
